Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Since Covid-19 first entered the global psyche in January this year, the pharmaceutical industry has committed itself to developing both vaccines and therapies to prevent and treat this deadly virus.
However, Access to Medicine Foundation research programme manager Danny Edwards argues that drug and vaccine development is “only half of the equation”.
As we move closer to a vaccine and more drugs being approved, it is time to focus on how ending this pandemic will also require global access to any effective treatments or vaccines developed.